Dementia in Parkinson's disease.
Dag Aarsland1, Mona K Beyer, Martin W Kurz
1Norwegian Centre for Movement Disorders, Stavenger University Hospital, Stavenger.
Current Opinion in Neurology
|November 8, 2008
Summary
Recent findings reveal new diagnostic criteria and a high prevalence of dementia in Parkinson's disease (PD). Research highlights alpha-synuclein's role and suggests subtypes of dementia in PD, paving the way for targeted treatments.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Cognitive impairment and dementia are common nonmotor symptoms in Parkinson's disease (PD).
- Understanding the clinical and neurobiological underpinnings of dementia in PD is crucial for patient care.
Purpose of the Study:
- To review recent clinical and neurobiological findings related to dementia in Parkinson's disease.
- To synthesize current knowledge on diagnostic criteria, prevalence, and underlying mechanisms.
Main Methods:
- Review of recent literature on dementia in Parkinson's disease.
- Analysis of new consensus criteria for diagnosis.
- Examination of pathological, genetic, imaging, and cerebrospinal fluid studies.
Main Results:
- New consensus criteria for diagnosing dementia in Parkinson's disease have been proposed.
- High cumulative prevalence of dementia in PD confirmed in long-term cohorts.
- Mild cognitive impairment in early PD predicts faster progression to dementia.
- Alpha-synuclein aggregation and other protein disturbances are linked to dementia in PD.
- Evidence suggests distinct subtypes of dementia in PD related to varying neuropathology.
Conclusions:
- Significant progress has been made in understanding the mechanisms of cognitive decline and dementia in PD.
- This enhanced understanding may facilitate the development of novel treatments to prevent or delay dementia onset.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.